Product Description
CJC-1295 NO DAC | 10mg
Researching Growth Hormone Signaling and Recovery
What It Does
CJC-1295 (no DAC) is being studied for its ability to stimulate natural growth hormone release in short, physiologic pulses. It acts on the pituitary to promote endogenous GH secretion, making it a focus in research exploring recovery, sleep quality, and metabolic regulation.
What Researchers Explore
- Pulsatile growth hormone release patterns
- Sleep quality and recovery mechanisms
- Lean body composition and fat metabolism
- Muscle recovery and performance pathways
- Skin and connective tissue support
- Bone density and structural integrity
Technical Background
CJC-1295 (no DAC) is a modified 29-amino acid analog of growth hormone-releasing hormone (GHRH) designed to stimulate endogenous GH secretion without extended half-life binding. Unlike DAC-modified versions, it does not bind to serum albumin, resulting in a shorter duration of action and more controlled, pulsatile GH release.
It activates GHRH receptors on pituitary somatotroph cells, triggering GH secretion through cAMP-mediated signaling pathways, closely mimicking natural physiologic GH rhythms.
Common Research Applications
- GHRH receptor and somatotroph activation studies
- Pulsatile GH secretion pattern research
- cAMP-PKA signaling pathway research
- Endogenous GH regulation studies
- Metabolic and recovery pathway research
- Short-acting peptide pharmacokinetics
Product Properties
Purity: 99%+ HPLC
Form: Lyophilized Powder
Size: 10mg
Category: Growth Hormone Research
Frequently Studied Together
- Ipamorelin (growth hormone secretagogue research)
- Sermorelin (GHRH analog research)
- Tesamorelin (GH pathway and fat metabolism research)
- IGF-1 LR3 (downstream growth factor signaling research)